Form 4: Abeona Therapeutics CFO Sells Shares to Cover Tax Obligations

Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics Inc., sold 17,795 shares of common stock on June 6, 2025, to satisfy tax obligations related to restricted stock awards.

Summary

• Joseph Walter Vazzano, the Chief Financial Officer of Abeona Therapeutics Inc. (ABEO), reported a sale of common stock.
• The transaction occurred on June 6, 2025.
• A total of 17,795 shares of common stock were disposed of.
• The shares were sold at a weighted average price of $6.76 per share, with prices ranging from $6.76 to $6.79.
• The purpose of the sale was to cover tax obligations associated with the vesting of restricted stock awards.
• Following this transaction, Mr. Vazzano directly beneficially owns 491,246 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary sale to cover tax obligations associated with restricted stock vesting, which is a common practice and does not typically signal a change in management's outlook on the company.

Positives

• The sale was explicitly stated to cover tax obligations related to the vesting of restricted stock awards, indicating a non-discretionary transaction rather than a lack of confidence in the company.

Negatives

• The transaction represents a reduction in the direct beneficial ownership of common stock by a key executive, albeit for a routine tax-related purpose.

Management Comments

• The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.

Stakeholder Impact

• Shareholders: The transaction is a routine insider sale for tax purposes and is unlikely to have a significant direct impact on shareholder value or perception, as it does not reflect a discretionary divestment.

Key Dates

Keywords

Abeona Therapeutics, ABEO, Joseph Walter Vazzano, CFO, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Obligations